<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have demonstrated previously that the protein tyrosine phosphatase SHP-1 seems to play a role in glial development and is upregulated in non-dividing astrocytes after injury </plain></SENT>
<SENT sid="1" pm="."><plain>The present study examines the effect of loss of SHP-1 on the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> response to permanent focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>SHP-1 deficient (me/me) mice and <z:mp ids='MP_0002169'>wild-type</z:mp> littermates received a permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>At 1, 3, and 7 days after MCAO, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, neuronal survival and cell <z:hpo ids='HP_0011420'>death</z:hpo>, <z:hpo ids='HP_0002171'>gliosis</z:hpo>, and inflammatory cytokine levels were quantified </plain></SENT>
<SENT sid="4" pm="."><plain>SHP-1 deficient me/me mice display smaller <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes at 7 days post-MCAO, increased neuronal survival within the ischemic penumbra, and decreased numbers of cleaved caspase 3+ cells within the ischemic core compared with <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, me/me mice exhibit increases in GFAP+ reactive astrocytes, F4-80+ microglia, and a concomitant increase in the level of interleukin 12 (IL-12) over baseline compared with <z:mp ids='MP_0002169'>wild-type</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Taken together, these results demonstrate that loss of SHP-1 results in greater healing of the <z:mpath ids='MPATH_124'>infarct</z:mpath> due to less <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and more neuronal survival in the ischemic core and suggests that pharmacologic inactivation of SHP-1 may have potential therapeutic value in limiting <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> degeneration after <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>